These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10613621)
1. Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects. Qin XP; Xie HG; Wang W; He N; Huang SL; Xu ZH; Ou-Yang DS; Wang YJ; Zhou HH Clin Pharmacol Ther; 1999 Dec; 66(6):642-6. PubMed ID: 10613621 [TBL] [Abstract][Full Text] [Related]
2. Voriconazole and fluconazole increase the exposure to oral diazepam. Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319 [TBL] [Abstract][Full Text] [Related]
3. Effect of sertraline on the pharmacokinetics and protein binding of diazepam in healthy volunteers. Gardner MJ; Baris BA; Wilner KD; Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():43-9. PubMed ID: 9068935 [TBL] [Abstract][Full Text] [Related]
4. Interethnic difference in omeprazole's inhibition of diazepam metabolism. Caraco Y; Tateishi T; Wood AJ Clin Pharmacol Ther; 1995 Jul; 58(1):62-72. PubMed ID: 7628184 [TBL] [Abstract][Full Text] [Related]
5. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Inomata S; Nagashima A; Itagaki F; Homma M; Nishimura M; Osaka Y; Okuyama K; Tanaka E; Nakamura T; Kohda Y; Naito S; Miyabe M; Toyooka H Clin Pharmacol Ther; 2005 Dec; 78(6):647-55. PubMed ID: 16338280 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Wang JH; Liu ZQ; Wang W; Chen XP; Shu Y; He N; Zhou HH Clin Pharmacol Ther; 2001 Jul; 70(1):42-7. PubMed ID: 11452243 [TBL] [Abstract][Full Text] [Related]
7. The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype. Wan J; Xia H; He N; Lu YQ; Zhou HH Br J Clin Pharmacol; 1996 Oct; 42(4):471-4. PubMed ID: 8904619 [TBL] [Abstract][Full Text] [Related]
8. Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam, oral clorazepate, and intravenous diazepam. Greenblatt DJ; Divoll MK; Soong MH; Boxenbaum HG; Harmatz JS; Shader RI J Clin Pharmacol; 1988 Sep; 28(9):853-9. PubMed ID: 2906643 [TBL] [Abstract][Full Text] [Related]
9. [Cytochrome P450 2C19 gene polymorphism in 104 Chinese Zang volunteers]. Ding HW; Dong WZ; Jiang ZG; Ma X Yi Chuan; 2004 Mar; 26(2):151-4. PubMed ID: 15639978 [TBL] [Abstract][Full Text] [Related]
10. CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects. Yin OQ; Tomlinson B; Chow MS Clin Pharmacol Ther; 2005 Oct; 78(4):370-7. PubMed ID: 16198656 [TBL] [Abstract][Full Text] [Related]
11. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability. Yin OQ; Tomlinson B; Chow AH; Waye MM; Chow MS J Clin Pharmacol; 2004 Jun; 44(6):582-9. PubMed ID: 15145965 [TBL] [Abstract][Full Text] [Related]
12. Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects. Liu ZQ; Cheng ZN; Huang SL; Chen XP; Ou-Yang DS; Jiang CH; Zhou HH Br J Clin Pharmacol; 2001 Jul; 52(1):96-9. PubMed ID: 11453896 [TBL] [Abstract][Full Text] [Related]
13. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Andersson T; Miners JO; Veronese ME; Birkett DJ Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation. Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765 [TBL] [Abstract][Full Text] [Related]
15. Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Kosuge K; Jun Y; Watanabe H; Kimura M; Nishimoto M; Ishizaki T; Ohashi K Drug Metab Dispos; 2001 Oct; 29(10):1284-9. PubMed ID: 11560871 [TBL] [Abstract][Full Text] [Related]
16. Direct evidence for the higher frequency of CYP2C19 allelic heterozygotes in Chinese subjects than in white subjects. Xie HG Clin Pharmacol Ther; 1997 Dec; 62(6):691-2. PubMed ID: 9433397 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects. Ieiri I; Kubota T; Urae A; Kimura M; Wada Y; Mamiya K; Yoshioka S; Irie S; Amamoto T; Nakamura K; Nakano S; Higuchi S Clin Pharmacol Ther; 1996 Jun; 59(6):647-53. PubMed ID: 8681489 [TBL] [Abstract][Full Text] [Related]
18. Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans. Shon JH; Yoon YR; Kim KA; Lim YC; Lee KJ; Park JY; Cha IJ; Flockhart DA; Shin JG Pharmacogenetics; 2002 Mar; 12(2):111-9. PubMed ID: 11875365 [TBL] [Abstract][Full Text] [Related]
19. CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. Zhou Q; Yamamoto I; Fukuda T; Ohno M; Sumida A; Azuma J Eur J Clin Pharmacol; 1999 Mar; 55(1):43-7. PubMed ID: 10206083 [TBL] [Abstract][Full Text] [Related]
20. Prolonged accumulation of diazepam in obesity. Abernethy DR; Greenblatt DJ; Divoll M; Shader RI J Clin Pharmacol; 1983; 23(8-9):369-76. PubMed ID: 6415130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]